[CLSTR]
< Back to situations

[ORGANIZATION]

GlaxoSmithKline

Featured in 12 tracked stories · first seen

Situations

[ACTIVE] [HEALTH] [US]

HPV vaccine dosage recommendation evaluation

2 clusters · 11 sources · last updated

Latest: HPV vaccine: Single-dose regimen under debate for cancer prevention

Medical experts are evaluating whether the human papillomavirus (HPV) vaccination schedule can be reduced from two doses to a single dose. This proposal aims to determine if a single dose provides sufficient protection f

[ACTIVE] [HEALTH] [IT]

Italy influenza and RSV vaccination preparations

10 clusters · 93 sources · last updated

Latest: Influenza monitoring intensifies ahead of 2026-2027 season

The 2026-2027 influenza vaccination campaign in Italy is moving toward its scheduled start. In Lombardy, the rollout begins October 1, prioritizing high-risk groups such as those over 60, pregnant women, children aged 6

[ACTIVE] [BUSINESS] [EG] [KW] [QA]

Egyptian market volatility follows record capitalisation

12 clusters · 14 sources · last updated

Latest: Egyptian Exchange hits two-month low amid foreign institutional buying

The Egyptian Exchange has transitioned through periods of record highs, volatility, and subsequent recovery. On August 16, the EGX30 reached a new record of 55,854.74 points, fueled by blue-chip stocks like Telecom Egypt

[QUIET] [BUSINESS] [DE] [CA]

GlaxoSmithKline Dresden vaccine plant closure

3 clusters · 14 sources · last updated

Latest: GSK vaccine plant in Dresden faces closure, threatening 641 jobs

GlaxoSmithKline (GSK) has announced plans to close its vaccine manufacturing facility in Dresden, Germany, by mid-2028. The closure will end 115 years of production at the site, known as the Sächsisches Serumwerk, which

[QUIET] [HEALTH] [US] [GB]

Shingles trends and Shingrix vaccine research

7 clusters · 36 sources · last updated

Latest: Medical research links shingles vaccines to lower dementia risk and identifies new neuralgia drivers

Recent data indicates a significant rise in shingles cases among younger adults, particularly millennial women in the United States and the United Kingdom. Research shows that cases among adults aged 30–49 in the U.S. mo

Also covered in